Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei in animal food: FDA records

What has FDA said about Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei in animal food?

FDA's animal food GRAS notices inventory lists 2 notices for Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei. AGRN 67 (filed Apr 15, 2024; intended species: Poultry): FDA's response, as the inventory prints it: "FDA has no questions" (letter dated Jan 10, 2025). AGRN 82 (filed Jul 15, 2025; intended species: Swine): FDA's response, as the inventory prints it: "FDA has no questions" (letter dated Feb 11, 2026).

Each notice covers the use and the animals it describes; FDA's response to one notice does not carry over to another use or species.

AAFCO ingredient definitions, published by the Association of American Feed Control Officials (a membership association, not a federal agency), are a separate list and are not covered here. A substance missing from these FDA records may still appear in that list or elsewhere.

FDA printed the name in more than one way: "Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei.", "Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei". They are listed together because the names are the same apart from capitals, spacing or punctuation.

GRAS notices

NotifierIntended useIntended species
67Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reesei.BASF CorporationUtility information not evaluated for GRAS, see FDA’s letter for more information.PoultryApr 15, 2024FDA has no questions.Jan 10, 2025
82Beta-mannanase from a Thermothelomyces thermophilus strain expressing an altered man1 gene from Trichoderma reeseiBASF CorporationUtility information not evaluated for GRAS, see FDA’s letter for more information.SwineJul 15, 2025FDA has no questionsFeb 11, 2026

FDA's letters, in FDA's words

“We have completed our evaluation of AGRN 67 and have no questions at this time.”

FDA, response letter on AGRN 67, dated Jan 10, 2025.

“We have completed our evaluation of AGRN 82 and have no questions at this time.”

FDA, response letter on AGRN 82, dated Feb 11, 2026.

Sentences are copied from the text of FDA's PDF letters. A sentence is left out when the PDF text could not be copied exactly (for example a number printed with an exponent).

See every animal food GRAS notice, the 21 CFR sections or all substances A to Z.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.

These are FDA records shown as FDA published them: notices, FDA's response wording and regulation headings. A record is not a finding by this site, and an FDA response to a GRAS notice covers the use and the animals the notice describes. AAFCO ingredient definitions, published by the Association of American Feed Control Officials (a membership association, not a federal agency), are a separate list and are not covered here. A substance missing from these FDA records may still appear in that list or elsewhere. Report an error or add a company response.